α-adrenoreceptor Antagonists
α-adrenoreceptor Antagonists market is segmented by region (country), players, by Type and by Ap ... Read More
Global and United States α-blocker Market Report & Forecast 2023-2028
1 Study Coverage
1.1 α-blocker Product Introduction
1.2 Global α-blocker Outlook 2017 VS 2022 VS 2028
1.2.1 Global α-blocker Sales in US$ Million for the Year 2017-2028
1.2.2 Global α-blocker Sales in Volume for the Year 2017-2028
1.3 United States α-blocker Outlook 2017 VS 2022 VS 2028
1.3.1 United States α-blocker Sales in US$ Million for the Year 2017-2028
1.3.2 United States α-blocker Sales in Volume for the Year 2017-2028
1.4 α-blocker Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States α-blocker in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of α-blocker Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 α-blocker Market Dynamics
1.5.1 α-blocker Industry Trends
1.5.2 α-blocker Market Drivers
1.5.3 α-blocker Market Challenges
1.5.4 α-blocker Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 α-blocker Market Segment by Type
2.1.1 Non-selective Antagonists
2.1.2 Selective Antagonists
2.2 Global α-blocker Market Size by Type
2.2.1 Global α-blocker Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global α-blocker Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global α-blocker Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States α-blocker Market Size by Type
2.3.1 United States α-blocker Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States α-blocker Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States α-blocker Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 α-blocker Market Segment by Application
3.1.1 Hypertension
3.1.2 Raynaud's Disease
3.1.3 Erectile Dysfunction
3.2 Global α-blocker Market Size by Application
3.2.1 Global α-blocker Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global α-blocker Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global α-blocker Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States α-blocker Market Size by Application
3.3.1 United States α-blocker Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States α-blocker Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States α-blocker Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global α-blocker Competitor Landscape by Company
4.1 Global α-blocker Market Size by Company
4.1.1 Top Global α-blocker Manufacturers Ranked by Revenue (2021)
4.1.2 Global α-blocker Revenue by Manufacturer (2017-2022)
4.1.3 Global α-blocker Sales by Manufacturer (2017-2022)
4.1.4 Global α-blocker Price by Manufacturer (2017-2022)
4.2 Global α-blocker Concentration Ratio (CR)
4.2.1 α-blocker Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of α-blocker in 2021
4.2.3 Global α-blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global α-blocker Manufacturing Base Distribution, Product Type
4.3.1 Global α-blocker Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers α-blocker Product Type
4.3.3 Date of International Manufacturers Enter into α-blocker Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States α-blocker Market Size by Company
4.5.1 Top α-blocker Players in United States, Ranked by Revenue (2021)
4.5.2 United States α-blocker Revenue by Players (2020, 2021 & 2022)
4.5.3 United States α-blocker Sales by Players (2020, 2021 & 2022)
5 Global α-blocker Market Size by Region
5.1 Global α-blocker Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global α-blocker Market Size in Volume by Region (2017-2028)
5.2.1 Global α-blocker Sales in Volume by Region: 2017-2022
5.2.2 Global α-blocker Sales in Volume Forecast by Region (2023-2028)
5.3 Global α-blocker Market Size in Value by Region (2017-2028)
5.3.1 Global α-blocker Sales in Value by Region: 2017-2022
5.3.2 Global α-blocker Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America α-blocker Market Size YoY Growth 2017-2028
6.1.2 North America α-blocker Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific α-blocker Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific α-blocker Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe α-blocker Market Size YoY Growth 2017-2028
6.3.2 Europe α-blocker Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America α-blocker Market Size YoY Growth 2017-2028
6.4.2 Latin America α-blocker Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa α-blocker Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa α-blocker Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer α-blocker Products Offered
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Corporation Information
7.2.2 Novartis Description and Business Overview
7.2.3 Novartis α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis α-blocker Products Offered
7.2.5 Novartis Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck α-blocker Products Offered
7.3.5 Merck Recent Development
7.4 Astra Zeneca
7.4.1 Astra Zeneca Corporation Information
7.4.2 Astra Zeneca Description and Business Overview
7.4.3 Astra Zeneca α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Astra Zeneca α-blocker Products Offered
7.4.5 Astra Zeneca Recent Development
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Corporation Information
7.5.2 Jhonson and Johnson Description and Business Overview
7.5.3 Jhonson and Johnson α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Jhonson and Johnson α-blocker Products Offered
7.5.5 Jhonson and Johnson Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Corporation Information
7.6.2 Eli Lilly Description and Business Overview
7.6.3 Eli Lilly α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Eli Lilly α-blocker Products Offered
7.6.5 Eli Lilly Recent Development
7.7 Sanofi
7.7.1 Sanofi Corporation Information
7.7.2 Sanofi Description and Business Overview
7.7.3 Sanofi α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sanofi α-blocker Products Offered
7.7.5 Sanofi Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb α-blocker Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer α-blocker Products Offered
7.9.5 Bayer Recent Development
7.10 GSK
7.10.1 GSK Corporation Information
7.10.2 GSK Description and Business Overview
7.10.3 GSK α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.10.4 GSK α-blocker Products Offered
7.10.5 GSK Recent Development
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Corporation Information
7.11.2 Teva Pharmaceutical Description and Business Overview
7.11.3 Teva Pharmaceutical α-blocker Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Teva Pharmaceutical α-blocker Products Offered
7.11.5 Teva Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 α-blocker Industry Chain Analysis
8.2 α-blocker Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 α-blocker Distributors
8.3 α-blocker Production Mode & Process
8.4 α-blocker Sales and Marketing
8.4.1 α-blocker Sales Channels
8.4.2 α-blocker Distributors
8.5 α-blocker Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. α-blocker CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. α-blocker Market Trends
Table 3. α-blocker Market Drivers
Table 4. α-blocker Market Challenges
Table 5. α-blocker Market Restraints
Table 6. Global α-blocker Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States α-blocker Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global α-blocker Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States α-blocker Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top α-blocker Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global α-blocker Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global α-blocker Revenue Share by Manufacturer, 2017-2022
Table 13. Global α-blocker Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global α-blocker Sales Share by Manufacturer, 2017-2022
Table 15. Global α-blocker Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global α-blocker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global α-blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in α-blocker as of 2021)
Table 18. Top Players of α-blocker in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers α-blocker Product Type
Table 20. Date of International Manufacturers Enter into α-blocker Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top α-blocker Players in United States Market, Ranking by Revenue (2021)
Table 23. United States α-blocker Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States α-blocker Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States α-blocker Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States α-blocker Sales Share by Players, 2020, 2021 & 2022
Table 27. Global α-blocker Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global α-blocker Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global α-blocker Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global α-blocker Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global α-blocker Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America α-blocker Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America α-blocker Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific α-blocker Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific α-blocker Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe α-blocker Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe α-blocker Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America α-blocker Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa α-blocker Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa α-blocker Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa α-blocker Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer α-blocker Product
Table 46. Pfizer Recent Development
Table 47. Novartis Corporation Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis Product
Table 51. Novartis Recent Development
Table 52. Merck Corporation Information
Table 53. Merck Description and Business Overview
Table 54. Merck α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Merck Product
Table 56. Merck Recent Development
Table 57. Astra Zeneca Corporation Information
Table 58. Astra Zeneca Description and Business Overview
Table 59. Astra Zeneca α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Astra Zeneca Product
Table 61. Astra Zeneca Recent Development
Table 62. Jhonson and Johnson Corporation Information
Table 63. Jhonson and Johnson Description and Business Overview
Table 64. Jhonson and Johnson α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Jhonson and Johnson Product
Table 66. Jhonson and Johnson Recent Development
Table 67. Eli Lilly Corporation Information
Table 68. Eli Lilly Description and Business Overview
Table 69. Eli Lilly α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Eli Lilly Product
Table 71. Eli Lilly Recent Development
Table 72. Sanofi Corporation Information
Table 73. Sanofi Description and Business Overview
Table 74. Sanofi α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Sanofi Product
Table 76. Sanofi Recent Development
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Business Overview
Table 79. Bristol-Myers Squibb α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bristol-Myers Squibb Product
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. GSK Product
Table 91. GSK Recent Development
Table 92. Teva Pharmaceutical Corporation Information
Table 93. Teva Pharmaceutical Description and Business Overview
Table 94. Teva Pharmaceutical α-blocker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Teva Pharmaceutical Product
Table 96. Teva Pharmaceutical Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. α-blocker Customers List
Table 100. α-blocker Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. α-blocker Product Picture
Figure 2. Global α-blocker Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global α-blocker Market Size 2017-2028 (US$ Million)
Figure 4. Global α-blocker Sales 2017-2028 (K Units)
Figure 5. United States α-blocker Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States α-blocker Market Size 2017-2028 (US$ Million)
Figure 7. United States α-blocker Sales 2017-2028 (K Units)
Figure 8. United States α-blocker Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States α-blocker Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. α-blocker Report Years Considered
Figure 11. Product Picture of Non-selective Antagonists
Figure 12. Product Picture of Selective Antagonists
Figure 13. Global α-blocker Market Share by Type in 2022 & 2028
Figure 14. Global α-blocker Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global α-blocker Sales Market Share in Value by Type (2017-2028)
Figure 16. Global α-blocker Sales by Type (2017-2028) & (K Units)
Figure 17. Global α-blocker Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global α-blocker Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States α-blocker Market Share by Type in 2022 & 2028
Figure 20. United States α-blocker Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States α-blocker Sales Market Share in Value by Type (2017-2028)
Figure 22. United States α-blocker Sales by Type (2017-2028) & (K Units)
Figure 23. United States α-blocker Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States α-blocker Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Hypertension
Figure 26. Product Picture of Raynaud's Disease
Figure 27. Product Picture of Erectile Dysfunction
Figure 28. Global α-blocker Market Share by Application in 2022 & 2028
Figure 29. Global α-blocker Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global α-blocker Sales Market Share in Value by Application (2017-2028)
Figure 31. Global α-blocker Sales by Application (2017-2028) & (K Units)
Figure 32. Global α-blocker Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global α-blocker Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States α-blocker Market Share by Application in 2022 & 2028
Figure 35. United States α-blocker Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States α-blocker Sales Market Share in Value by Application (2017-2028)
Figure 37. United States α-blocker Sales by Application (2017-2028) & (K Units)
Figure 38. United States α-blocker Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States α-blocker Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America α-blocker Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America α-blocker Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe α-blocker Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe α-blocker Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific α-blocker Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific α-blocker Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America α-blocker Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America α-blocker Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa α-blocker Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa α-blocker Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E α-blocker Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. α-blocker Value Chain
Figure 74. α-blocker Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Novartis Merck Astra Zeneca Jhonson and Johnson Eli Lilly Sanofi Bristol-Myers Squibb Bayer GSK Teva Pharmaceutical